SIX1 and hepatocellular carcinoma: About 71% of HCC patients recognised at the advanced pTNM stage (45 of 63) or with venous infiltration (42 of 59) were found to overexpress Six1 protein, suggesting that Six1 may play an important role on HCC progression and invasion.